Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Ethadox Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is located within 1 distinct art unit and is assigned to 1 distinct examiner. The current prosecution activity is focused on this single pending application. This concentration in the Biotechnology sector indicates a specific technical priority for the company's current intellectual property efforts.
MARSHA M TSAY is the busiest examiner for the portfolio, managing the 1 pending office action. With 1 distinct examiner overseeing the 1 pending matter, the prosecution is centralized. This allows the company to address the examiner's specific feedback within the Biotechnology sector directly. The applicant can focus on building a consistent record with MARSHA M TSAY, as there are no other examiners or art units currently involved in the company's active prosecution.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TSAY, MARSHA M | 1 | 45.5% | +52.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18811618 | COMPOSITIONS AND METHODS FOR BIODEGRADING ALCOHOL | TSAY, MARSHA M | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18811618 | COMPOSITIONS AND METHODS FOR BIODEGRADING ALCOHOL | TSAY, MARSHA M | 1656 | §103 | Non-Final OA | — | Pending | Aug 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEthadox Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Marsha M Tsay has the most, with 1 of Ethadox Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
